Analgesics - Hungary

  • Hungary
  • In Hungary, the revenue in the Analgesics market is estimated to reach US$89.94m in 2024.
  • It is projected to experience an annual growth rate of 6.55% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue, amounting to US$7,243.00m in 2024.
  • In terms of per person revenues, in Hungary generates approximately US$9.00 per individual in 2024.
  • With a strong preference for traditional remedies, Hungary's analgesics market sees a surge in demand for herbal and natural pain relief products.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Hungary has been experiencing steady growth in recent years.

Customer preferences:
Hungarian consumers have shown a growing demand for analgesics due to several factors. Firstly, the aging population in Hungary has led to an increase in chronic pain conditions, such as arthritis and back pain, which require regular pain relief medication. Additionally, the increasing awareness and acceptance of self-medication among Hungarian consumers have contributed to the growth of the analgesics market. Consumers are becoming more proactive in managing their health and are seeking over-the-counter pain relief options.

Trends in the market:
One of the key trends in the Hungarian analgesics market is the shift towards natural and herbal remedies. Consumers are increasingly looking for products that are perceived as more natural and have fewer side effects. This has led to the rise in popularity of herbal analgesics, such as those containing ingredients like arnica or willow bark. Manufacturers have responded to this trend by introducing a wider range of natural analgesic products to cater to the growing demand.Another trend in the market is the increasing availability of analgesics in different formats. While traditional tablets and capsules continue to dominate the market, there has been a rise in the popularity of alternative formats such as gels, creams, and patches. These formats offer targeted pain relief and convenience, allowing consumers to apply the medication directly to the affected area.

Local special circumstances:
One of the unique aspects of the Hungarian market is the strong presence of domestic pharmaceutical companies. These companies have a deep understanding of the local market and consumer preferences, allowing them to effectively compete with multinational players. Domestic companies often focus on providing affordable analgesic options, which resonates well with price-sensitive Hungarian consumers.

Underlying macroeconomic factors:
The growing analgesics market in Hungary is also influenced by several macroeconomic factors. The country has experienced stable economic growth in recent years, which has contributed to an increase in disposable incomes. As consumers have more purchasing power, they are more willing to spend on healthcare products, including analgesics. Additionally, the government's focus on improving healthcare infrastructure and services has also played a role in driving the demand for analgesics.In conclusion, the Analgesics market in Hungary is experiencing steady growth due to customer preferences for pain relief options, such as natural and herbal remedies, and the availability of analgesics in different formats. The presence of domestic pharmaceutical companies and favorable macroeconomic factors further contribute to the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)